Medical Training AIBody Composition Assessment
You'll be able to select and interpret DEXA, BIA, and anthropometric measures to guide and monitor weight loss treatment beyond scale weight alone.
What this track covers
This track covers how fat mass, lean mass, and visceral adipose tissue relate to metabolic risk, and how DEXA, BIA, and clinical anthropometrics differ in what they measure and where they fall short. It also addresses recognizing sarcopenic obesity and tracking body composition changes during treatment, not just weight change.
What you will practice
- Choose an appropriate assessment method based on patient presentation and available tools
- Distinguish fat mass loss from lean mass loss when reviewing serial measurements
- Flag patients at risk for sarcopenic obesity despite a 'normal' BMI
- Explain DEXA or BIA results to a patient in plain language
- Identify when a measurement method's limitations could mislead a treatment decision
Simulator scenario
A patient several months into a weight loss program has lost weight on the scale but reports feeling weaker, prompting the clinician to review body composition data and decide whether to adjust the treatment plan.
Board question topics
- Interpreting fat mass vs. lean mass trends over time
- Recognizing visceral adipose tissue risk patterns
- Comparing strengths and limitations of DEXA vs. BIA
- Identifying sarcopenic obesity in a normal-BMI patient
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free